| Literature DB >> 35830389 |
Mulugeta W/Mariam Beyen1, Gizachew Abdissa Bulto2, Eshetu Ejeta Chaka3, Bikila Tefera Debelo2, Ephrem Yohannes Roga2, Negash Wakgari2, Kababa Temesgen Danusa2, Daniel Belema Fekene2.
Abstract
BACKGROUND: The Human Papillomavirus (HPV) vaccine has offered a great promise to reduce the cervical cancer burden; its utilization (uptake) however has been lagging. However, the levels and factors associated with the uptake of the vaccine have not been well investigated, especially in the local context.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35830389 PMCID: PMC9278730 DOI: 10.1371/journal.pone.0271237
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Socio-demographic characteristics, of adolescent school girls in Ambo town, Ethiopia, 2020 (n = 414).
| Socio-demographic characteristics | Frequency | Percent (%) | |
|---|---|---|---|
|
| 14–15 years | 199 | 48.1 |
| 16–18 years | 215 | 51.9 | |
|
| Orthodox | 157 | 37.9 |
| Protestant | 210 | 50.7 | |
| Others | 47 | 11.4 | |
|
| No formal education | 155 | 37.4 |
| Primary education | 107 | 25.9 | |
| Secondary education | 62 | 15.0 | |
| College Diploma and above | 90 | 21.7 | |
|
| No formal education | 183 | 44.1 |
| Primary education | 112 | 27.1 | |
| Secondary education | 76 | 18.4 | |
| College diploma and above | 43 | 10.4 | |
|
| Farmer | 198 | 47.8 |
| Government employee | 118 | 28.6 | |
| Merchant | 42 | 10.1 | |
| Other | 56 | 13.5 | |
|
| Farmer | 150 | 36.2 |
| Housewife | 102 | 24.6 | |
| Government employee | 58 | 14.0 | |
| Merchant | 58 | 14.0 | |
| Other | 46 | 11.1 | |
*Muslim, Waqeffata, Catholic,
**Prophesier, private employee
Bivariate and multivariable logistic analysis to identify factors associated with uptake of HPV vaccination among adolescent school girls in Ambo town, Ethiopia, 2020 (n = 414).
| Variables | Uptake | COR (CI 95%) | AOR (95% CI) | P-value | |||
|---|---|---|---|---|---|---|---|
| Received | Not received | P-value | |||||
|
| |||||||
| | 95(23) | 73(17.6) | .000 | 2.296(1.538, 3.428) | .732(.324, 1.654) | .454 | |
| | 89(21.5) | 157(37.9) | 1.0 | 1.0 | |||
|
| |||||||
| | 171(41.3) | 155(37.4) | .000 | 6.365(3.398, 11.923) | 2.495(1.045,5.959) | .040 | |
| | 13(3.1) | 75(18.2) | 1.0 | 1.0 | |||
|
| |||||||
| | 135(32.6) | 104(25.2) | .000 | 3.338(2.199, 5.067) | 2.049(1.153, 3.640) | . 014 | |
| | 49(11.8) | 126(30.4) | 1.0 | 1.0 | |||
|
| |||||||
|
| |||||||
| | 75(18.1) | 56(13.5) | .000 | 2.138(1.403, 3.257) | 1.145(.668,1.963) | .623 | |
| | 109(26.3) | 174(42.1) | 1.0 | 1.0 | |||
|
| |||||||
| | 125(30.2) | 76(18.4) | .000 | 4.293(2.838, 6.494) | 2.533(1.507, 4.258) | < .001 | |
| | 59(14.1) | 154(37.3) | 1.0 | 1.0 | |||
|
| |||||||
| | 119(28.8) | 119(28.7) | . 008 | 1.708(1.147, 2.542) | .892(.536, 1.483) | .660 | |
| | 65(15.7) | 111(26.8) | 1.0 | 1.0 | |||
*statistically significant at p< 0.05 with COR: crude odds ratio AOR, adjusted odds ratio
**HPV- human papillomavirus